|
Variables | Deceased patients (n = 1,149) | Recovered patients (n = 1,342) | P-value |
|
Mean age ± SD | 59.3 ± 10.9 | 50.9 ± 12.9 | |
Gender (male/female) | 611/538 (53.2/46.8%) | 697/645 (51.9/48.1%) | 0.535 |
ALT, IU/L (mean ± SD) (reference range: 5–40) | 44.5 ± 23.9 | 33.2 ± 24.3 | |
AST, IU/L (mean ± SD) (reference range: 5–40) | 36.9 ± 13.0 | 31.3 ± 15.7 | |
ALP, IU/L (mean ± SD) (reference range: up to 306) | 201.9 ± 66.3 | 171.0 ± 90.6 | |
Cholesterol, mg/dL (mean ± SD) (reference range: 50–200) | 116.6 ± 38.9 | 121.8 ± 36.3 | |
TG, mg/dL (mean ± SD) (reference range: 60–165) | 116.6 ± 41.7 | 131.5 ± 61.5 | |
LDL, mg/dL (mean ± SD) (reference range: up to 150) | 70.2 ± 35.6 | 107.1 ± 49.3 | |
HDL, mg/dL (mean ± SD) (reference range: >40) | 30.6 ± 10.9 | 34.4 ± 11.6 | |
WBC, 109/L (mean ± SD) (reference range: 4,000–10,000) | 7,544.4 ± 2,663.4 | 7,717.4 ± 2,897.6 | 0.347 |
CRP, mg/L (mean ± SD) (reference range: <10 mg/L Negative) | 67.3 ± 21.4 | 56.9 ± 20.9 | |
ESR, mm/1st hr (mean ± SD) (reference range: 0–15) | 54.5 ± 15.6 | 46.5 ± 15.3 | |
FBS, mg/dL (mean ± SD) (reference range: 70–100) | 110.7 ± 42.9 | 105.6 ± 41.3 | |
Platelets × 1,000/cumm (mean ± SD) (reference range: 140,000–400,000) | 186 ± 76 | 185 ± 65 | 0.206 |
Uric acid, mg/dL (mean ± SD) (reference range: 3.6–6.8) | 3.9 ± 1.2 | 5.6 ± 1.4 | |
Cr, mg/dL (mean ± SD) (reference range: 0.6–1.4) | 1.2 ± 0.3 | 0.7 ± 0.2 | |
T3, ng/dL (mean ± SD) (reference range: 2.3–4.2) | 3.1 ± 1.2 | 2.5 ± 0.8 | 0.061 |
T4, mcg/dL (mean ± SD) (reference range: 5.6–13.7) | 8.9 ± 4.6 | 8.3 ± 3.3 | 0.091 |
TSH, mu/L (mean ± SD) (reference range: 0.4–4.5) | 3.5 ± 1.4 | 3.3 ± 1.2 | 0.384 |
25-Hydroxy vitamin D, ng/mL (mean ± SD) (sufficiency: 21–150) | 25.3 ± 10.1 | 35.9 ± 13.4 | |
Real-time PCR Ct values | 13.1 ± 5.7 | 28.1 ± 8.1 | |
|